BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30246632)

  • 21. Vesicular carriers for skin drug delivery: the Pheroidâ„¢ technology.
    Kilian D; Shahzad Y; Fox L; Gerber M; Du Plessis J
    Curr Pharm Des; 2015; 21(20):2758-70. PubMed ID: 25925120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.
    Desai P; Patlolla RR; Singh M
    Mol Membr Biol; 2010 Oct; 27(7):247-59. PubMed ID: 21028936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentials of new nanocarriers for dermal and transdermal drug delivery.
    Neubert RH
    Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
    Takeuchi I; Takeshita T; Suzuki T; Makino K
    Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Vesicular Bilosomal Delivery Systems for Dermal/Transdermal Applications.
    Suvarna V; Mallya R; Deshmukh K; Sawant B; Khan TA; Omri A
    Curr Drug Deliv; 2024; 21(7):961-977. PubMed ID: 37424346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties.
    Gu Y; Yang M; Tang X; Wang T; Yang D; Zhai G; Liu J
    J Nanobiotechnology; 2018 Sep; 16(1):68. PubMed ID: 30217198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
    Ahmed TA; El-Say KM
    Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of polymeric colloidal nanogels in transdermal drug delivery.
    Mavuso S; Marimuthu T; Choonara YE; Kumar P; du Toit LC; Pillay V
    Curr Pharm Des; 2015; 21(20):2801-13. PubMed ID: 25925117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proniosomes in transdermal drug delivery.
    Rahimpour Y; Kouhsoltani M; Hamishehkar H
    Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanosized particulate systems for dermal and transdermal delivery.
    Hassan AO; Elshafeey AH
    J Biomed Nanotechnol; 2010 Dec; 6(6):621-33. PubMed ID: 21361126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel strategies for effective transdermal drug delivery: a review.
    Jain A; Jain P; Kurmi J; Jain D; Jain R; Chandel S; Sahu A; Mody N; Upadhaya S; Jain A
    Crit Rev Ther Drug Carrier Syst; 2014; 31(3):219-72. PubMed ID: 24940749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking the skin barrier: achievements and future directions.
    Zhang H; Zhai Y; Yang X; Zhai G
    Curr Pharm Des; 2015; 21(20):2713-24. PubMed ID: 25925124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview.
    Shakeel F; Shafiq S; Haq N; Alanazi FK; Alsarra IA
    Expert Opin Drug Deliv; 2012 Aug; 9(8):953-74. PubMed ID: 22703228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer-Aided Design of Nanoparticles for Transdermal Drug Delivery.
    Gupta R; Rai B
    Methods Mol Biol; 2020; 2059():225-237. PubMed ID: 31435925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances and development in epidermal and dermal drug deposition enhancement technology.
    Iqbal B; Ali J; Baboota S
    Int J Dermatol; 2018 Jun; 57(6):646-660. PubMed ID: 29430629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.